LYELL IMMUNOPHARMA INC
Q1 2026 13F Holders
Symbol
LYEL
CUSIP
55083R203
Type
Equity
Class
COM NEW
Num filings
76
Total reported value, excl. options
$237 M
Compare 2026 Q1 to
2026 Q3
2026 Q2
2025 Q4
2025 Q3
2025 Q2
Manager
Report Date
Value ($000)
Shares
Option Type